In another study, it was observed that non-small cell lung cancer cells respond differently to Op18/stathmin signaling when autocrine IL-10 is neutralized in vitro. Bioflavonoids are therapeutic potential candidates for lung cancer treatment. This evidence concerns the gene STMN1 and lung carcinoma.